|
Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial
Science 2.0 A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers. The randomized, double-blind, placebo-controlled trial tested the efficacy … |
View full post on asthma – Google News